Raphas Co. Ltd (214260) - Net Assets
Based on the latest financial reports, Raphas Co. Ltd (214260) has net assets worth ₩27.54 Billion KRW (≈ $18.66 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩67.97 Billion ≈ $46.06 Million USD) and total liabilities (₩40.43 Billion ≈ $27.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Raphas Co. Ltd (214260) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩27.54 Billion |
| % of Total Assets | 40.52% |
| Annual Growth Rate | 3.27% |
| 5-Year Change | -41.34% |
| 10-Year Change | N/A |
| Growth Volatility | 49.58 |
Raphas Co. Ltd - Net Assets Trend (2017–2025)
This chart illustrates how Raphas Co. Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Raphas Co. Ltd (214260) market capitalisation.
Annual Net Assets for Raphas Co. Ltd (2017–2025)
The table below shows the annual net assets of Raphas Co. Ltd from 2017 to 2025. Also explore net asset growth rate of Raphas Co. Ltd to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩30.71 Billion ≈ $20.81 Million |
+4.60% |
| 2024-12-31 | ₩29.36 Billion ≈ $19.90 Million |
-9.12% |
| 2023-12-31 | ₩32.31 Billion ≈ $21.89 Million |
-21.06% |
| 2022-12-31 | ₩40.93 Billion ≈ $27.74 Million |
-21.83% |
| 2021-12-31 | ₩52.36 Billion ≈ $35.48 Million |
+18.51% |
| 2020-12-31 | ₩44.18 Billion ≈ $29.94 Million |
-7.63% |
| 2019-12-31 | ₩47.83 Billion ≈ $32.42 Million |
+137.59% |
| 2018-12-31 | ₩20.13 Billion ≈ $13.64 Million |
-15.21% |
| 2017-12-31 | ₩23.74 Billion ≈ $16.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Raphas Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 464138289000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩33.43 Billion | 117.97% |
| Total Equity | ₩28.33 Billion | 100.00% |
Raphas Co. Ltd Competitors by Market Cap
The table below lists competitors of Raphas Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EstechPharma Co. Ltd
KQ:041910
|
$42.74 Million |
|
Dongyang Expre
KO:084670
|
$42.79 Million |
|
Ocumetics Technology Corp
V:OTC
|
$42.80 Million |
|
Grupo Pochteca S.A.B. de C.V
MX:POCHTECB
|
$42.82 Million |
|
Dongwon Metal
KO:018500
|
$42.73 Million |
|
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
|
$42.73 Million |
|
Econpile Holdings Bhd
KLSE:5253
|
$42.71 Million |
|
Goodyear (Thailand) Public Company Limited
BK:GYT
|
$42.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Raphas Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 29,362,408,780 to 28,333,093,540, a change of -1,029,315,240 (-3.5%).
- Net loss of 4,314,426,620 reduced equity.
- Other factors increased equity by 3,285,111,380.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-4.31 Billion | -15.23% |
| Other Changes | ₩3.29 Billion | +11.59% |
| Total Change | ₩- | -3.51% |
Book Value vs Market Value Analysis
This analysis compares Raphas Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩3523.07 | ₩7500.00 | x |
| 2018-12-31 | ₩2987.35 | ₩7500.00 | x |
| 2019-12-31 | ₩5733.04 | ₩7500.00 | x |
| 2020-12-31 | ₩5248.46 | ₩7500.00 | x |
| 2021-12-31 | ₩6092.15 | ₩7500.00 | x |
| 2022-12-31 | ₩4839.82 | ₩7500.00 | x |
| 2023-12-31 | ₩3445.48 | ₩7500.00 | x |
| 2024-12-31 | ₩3492.01 | ₩7500.00 | x |
| 2025-12-31 | ₩3369.59 | ₩7500.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Raphas Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.92%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 2.65x
- Recent ROE (-15.23%) is below the historical average (-13.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -22.76% | -77.90% | 0.20x | 1.47x | ₩-7.78 Billion |
| 2018 | -19.09% | -38.23% | 0.29x | 1.71x | ₩-5.86 Billion |
| 2019 | 0.26% | 0.69% | 0.29x | 1.31x | ₩-4.66 Billion |
| 2020 | -10.28% | -25.42% | 0.30x | 1.35x | ₩-8.96 Billion |
| 2021 | 9.42% | 24.24% | 0.21x | 1.87x | ₩-305.77 Million |
| 2022 | -20.79% | -36.00% | 0.25x | 2.35x | ₩-12.60 Billion |
| 2023 | -29.80% | -31.52% | 0.28x | 3.40x | ₩-11.76 Billion |
| 2024 | -16.25% | -17.53% | 0.36x | 2.59x | ₩-7.71 Billion |
| 2025 | -15.23% | -13.92% | 0.41x | 2.65x | ₩-7.15 Billion |
Industry Comparison
This section compares Raphas Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $381,088,619,669
- Average return on equity (ROE) among peers: -4.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Raphas Co. Ltd (214260) | ₩27.54 Billion | -22.76% | 1.47x | $42.74 Million |
| ORIENTBIO Inc. (002630) | $48.55 Billion | -31.47% | 0.47x | $73.37 Million |
| Green Cross (005250) | $1.38 Trillion | 3.43% | 0.63x | $290.81 Million |
| Green Cross Holdings Preference Shares (005257) | $1.51 Trillion | 0.20% | 0.84x | $2.97 Million |
| Pharmicell (005690) | $94.60 Billion | -0.72% | 0.08x | $509.52 Million |
| GeneOne Life Science Inc (011000) | $33.79 Billion | 0.00% | 0.20x | $32.81 Million |
| HLB Co. Ltd (028300) | $582.25 Billion | -32.21% | 0.29x | $2.67 Billion |
| Mgenplus Co. Ltd. (032790) | $44.12 Billion | 7.01% | 0.62x | $22.01 Million |
| Daesung Microbiological Labs. Co. Ltd (036480) | $35.42 Billion | 1.69% | 0.64x | $15.84 Million |
| Seoulin Bioscience Co.Ltd (038070) | $41.57 Billion | 10.01% | 0.45x | $24.32 Million |
| Hyundai Bioscience Co. Ltd (048410) | $46.99 Billion | 1.63% | 0.35x | $444.71 Million |
About Raphas Co. Ltd
Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more